Vertex and Arbor Biotechnologies partner to develop novel ex-vivo engineered cell therapies EP News Bureau Aug 25, 2021 Vertex to use Arbor’s CRISPR gene-editing technology to enhance efforts in developing novel cell therapies for the treatment of…
